150 related articles for article (PubMed ID: 37902122)
21. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
22. Past, Present, and Future of Familial Hypercholesterolemia Management.
Rocha VZ; Santos RD
Methodist Debakey Cardiovasc J; 2021; 17(4):28-35. PubMed ID: 34824679
[TBL] [Abstract][Full Text] [Related]
23. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
[TBL] [Abstract][Full Text] [Related]
24. Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
Clarke SL
Curr Opin Lipidol; 2023 Apr; 34(2):52-58. PubMed ID: 36853849
[TBL] [Abstract][Full Text] [Related]
25. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
26. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
Miname MH; Santos RD
Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
[TBL] [Abstract][Full Text] [Related]
27. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
Vuorio A; Kovanen PT
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the management and implementation of care for familial hypercholesterolaemia.
Lan NSR; Bajaj A; Watts GF; Cuchel M
Pharmacol Res; 2023 Aug; 194():106857. PubMed ID: 37460004
[TBL] [Abstract][Full Text] [Related]
29. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
[TBL] [Abstract][Full Text] [Related]
30. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.
Bell DA; Hooper AJ; Watts GF; Burnett JR
Vasc Health Risk Manag; 2012; 8():651-9. PubMed ID: 23226021
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632
[TBL] [Abstract][Full Text] [Related]
32. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
Perak AM; Ning H; de Ferranti SD; Gooding HC; Wilkins JT; Lloyd-Jones DM
Circulation; 2016 Jul; 134(1):9-19. PubMed ID: 27358432
[TBL] [Abstract][Full Text] [Related]
34. Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies.
Pasta A; Cremonini AL; Formisano E; Fresa R; Bertolini S; Pisciotta L
Atherosclerosis; 2020 Sep; 308():6-14. PubMed ID: 32771803
[TBL] [Abstract][Full Text] [Related]
35. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia.
Peterson AL; McNeal CJ; Wilson DP
Curr Atheroscler Rep; 2021 Aug; 23(10):64. PubMed ID: 34453222
[TBL] [Abstract][Full Text] [Related]
36. Search for familial hypercholesterolemia patients in an Italian community: A real-life retrospective study.
Fasano T; Trenti C; Negri EA; Guiducci V; Foracchia M; Bonelli E; Canovi S; Besutti G; Bertolini S; Calandra S
Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):577-585. PubMed ID: 35123858
[TBL] [Abstract][Full Text] [Related]
37. Unveiling Familial Hypercholesterolemia-Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy.
Fularski P; Hajdys J; Majchrowicz G; Stabrawa M; Młynarska E; Rysz J; Franczyk B
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338916
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.
Ogura M; Harada-Shiba M; Masuda D; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S; Yamashita S
J Atheroscler Thromb; 2022 Jun; 29(6):906-922. PubMed ID: 34108342
[TBL] [Abstract][Full Text] [Related]
39. [Screening for familial hypercholesterolemia from low-density lipoprotein cholesterol levels at admission in the coronary care unit].
Chemaly P; Nallet O; Delarche N; Legagneur C; Boulestreau R; Reibel I; Palette C; Grenier A; Courtade H; Beaune G; Belle L; Georges JL
Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):300-309. PubMed ID: 30290906
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
